Atara Biotherapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ATRA Nasdaq 2830 www.atarabio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Atara Biotherapeutics, Inc.

Biotech Stocks Surge As UniQure 'Nail-Biting Journey' Comes To An End - Jun 17th, 2026 2:15 pm
FDA Resubmission Path for Tab-cel Keeps Atara’s (ATRA) Regulatory Timeline Alive - May 7th, 2026 9:03 am
Atara Biotherapeutics, Inc. (ATRA) Registers Possible Resale of 400K Common Shares Tied to HCR Warrant Exercise - Apr 2nd, 2026 6:02 pm
Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx - Apr 1st, 2026 6:01 am
Pierre Fabre seeks to revive US approval chances for spurned cell therapy - Mar 3rd, 2026 4:52 am
Top Midday Decliners - Jan 13th, 2026 12:14 pm
AbbVie buys into PD-1/VEGF sweepstakes; Alnylam and Vertex set expectations - Jan 12th, 2026 4:24 am